Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramOfficers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.
Kurtz George0B / 220S220 trades$52.89M
Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
TSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
DRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
MTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
MSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
FFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
MGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
SYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
UPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 4 | Hanna John Walter JRDirector, President and CEO |  CDNACareDx, Inc.Open-market sale · 10b5-1 plan | SELL | $217K 10.3K sh | Apr 20, 2026 |
| 4 | Cheng Chi FungDirector, Chief Technology Officer |  CRDOCredo Technology Group Holding LtdOpen-market sale · 10b5-1 plan | SELL | $872K 5,545 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 3 | Hulls ChrisDirector |  LIFLife360, Inc.Option exercise · 10b5-1 plan | M | — 27.0K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 3 | Munagala DinakarDirector, Chief Executive Officer |  BZAIBlaize Holdings, Inc.Option exercise · 10b5-1 plan | M | $28K 50.0K sh | Apr 20, 2026 traded Apr 17, 2026 |
| 3 | Wong Jennifer L.Chief Operating Officer | RDDTReddit, Inc. Open-market sale · 10b5-1 plan | SELL | $33K 200 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 3 | Gruber JulieChief Legal&Compliance Officer |  GAPGAP INCOption exercise · 10b5-1 plan | M | — 5,302 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 1 | Rosenbaum Michael GeorgeDirector, Chief Executive Officer |  GWREGuidewire Software, Inc.Open-market sale · 10b5-1 plan | SELL | $168K 1,200 sh | Apr 20, 2026 traded Apr 20, 2026 |
| 1 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $71K 440 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 1 | Brown Michael DeanDirector, See Remarks |  TNLTravel & Leisure Co.Option exercise · 10b5-1 plan | M | $419K 9,443 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 1 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $139K 900 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Chairman DavidSVP, R&D |  VLNValens Semiconductor Ltd.Option exercise · 10b5-1 plan | M | $2,050 2,384 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Michaels Adam LauranceDirector, Chief Executive Officer |  MAMAMama's Creations, Inc.Grant or award · 10b5-1 plan | A | — 82.3K sh | Apr 20, 2026 traded Apr 17, 2026 |
| 0 | Ribeiro RamiroChief Medical Officer |  EYPTEyePoint, Inc.Option exercise · 10b5-1 plan | M | $20K 2,437 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 0 | Mazumdar ClaireDirector, Chief Executive Officer |  BCAXBicara Therapeutics Inc.Option exercise · 10b5-1 plan | M | — 8,226 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Munagala DinakarDirector, Chief Executive Officer | BZAIBlaize Holdings, Inc. Option exercise · 10b5-1 plan | M | — 50.0K sh | Apr 20, 2026 traded Apr 17, 2026 |
| 0 |  Bhatt BaijuDirector | HOODRobinhood Markets, Inc. Derivative conversion · 10b5-1 plan | C | — 57.3K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Saha AnuragCHIEF ACCOUNTING OFFICER | CRWDCrowdStrike Holdings, Inc. Grant or award · 10b5-1 plan | A | — 9,681 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Mazumdar ClaireDirector, Chief Executive Officer | BCAXBicara Therapeutics Inc. Option exercise · 10b5-1 plan | M | — 15.0K sh | Apr 20, 2026 traded Apr 20, 2026 |
| 0 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $17K 100 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Clark Joseph GatesSVP and Pres, Optimized LED |  PENGPenguin Solutions, Inc.Tax withholding · 10b5-1 plan | F | $61K 2,288 sh | Apr 20, 2026 traded Apr 20, 2026 |
| 0 | Mazumdar ClaireDirector, Chief Executive Officer | BCAXBicara Therapeutics Inc. Option exercise · 10b5-1 plan | M | $57K 15.0K sh | Apr 20, 2026 traded Apr 20, 2026 |
| 0 | Saha AnuragCHIEF ACCOUNTING OFFICER | CRWDCrowdStrike Holdings, Inc. Grant or award · 10b5-1 plan | A | — 7,260 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Chairman DavidSVP, R&D | VLNValens Semiconductor Ltd. Option exercise · 10b5-1 plan | M | — 2,384 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Mazumdar ClaireDirector, Chief Executive Officer | BCAXBicara Therapeutics Inc. Option exercise · 10b5-1 plan | M | $36K 8,226 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Brown Michael DeanDirector, See Remarks | TNLTravel & Leisure Co. Option exercise · 10b5-1 plan | M | — 1,109 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Mazumdar ClaireDirector, Chief Executive Officer | BCAXBicara Therapeutics Inc. Option exercise · 10b5-1 plan | M | — 7,080 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Wong Jennifer L.Chief Operating Officer | RDDTReddit, Inc. Option exercise · 10b5-1 plan | M | — 39.2K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Mazumdar ClaireDirector, Chief Executive Officer | BCAXBicara Therapeutics Inc. Option exercise · 10b5-1 plan | M | $39K 7,080 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Okupe OluyemiChief Financial Officer |  HIMSHims & Hers Health, Inc.Option exercise · 10b5-1 plan | M | $31K 6,184 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 0 | Ribeiro RamiroChief Medical Officer | EYPTEyePoint, Inc. Option exercise · 10b5-1 plan | M | — 2,437 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 0 | Bhatt BaijuDirector | HOODRobinhood Markets, Inc. Derivative conversion · 10b5-1 plan | C | — 57.3K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Wong Jennifer L.Chief Operating Officer | RDDTReddit, Inc. Option exercise · 10b5-1 plan | M | $210K 39.2K sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Okupe OluyemiChief Financial Officer | HIMSHims & Hers Health, Inc. Option exercise · 10b5-1 plan | M | — 6,184 sh | Apr 20, 2026 traded Apr 17, 2026 |
| 0 | Mazumdar ClaireDirector, Chief Executive Officer | BCAXBicara Therapeutics Inc. Option exercise · 10b5-1 plan | M | $28K 7,454 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Brown Michael DeanDirector, See Remarks | TNLTravel & Leisure Co. Option exercise · 10b5-1 plan | M | $49K 1,109 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 0 | Mazumdar ClaireDirector, Chief Executive Officer | BCAXBicara Therapeutics Inc. Option exercise · 10b5-1 plan | M | — 7,454 sh | Apr 20, 2026 traded Apr 16, 2026 |
| 52 | Earl JohnPresident | NAKeystone Private Income Fund Open-market purchase | BUY | $3.00M 30.6K sh | Apr 17, 2026 traded Apr 1, 2026 |
| 47 | Ballou-Aares DaniellaDirector |  IBEXIBEX LtdOpen-market sale | SELL | $142K 5,843 sh | Apr 17, 2026 traded Mar 13, 2025 |
| 44 | Venturo Brian MDirector, Chief Strategy Officer | CRWVCoreWeave, Inc. Open-market sale · 10b5-1 plan | SELL | $3.43M 28.9K sh | Apr 17, 2026 traded Apr 15, 2026 |
| 41 | Gerber CharlesTrustee |  DHYCREDIT SUISSE HIGH YIELD CREDIT FUNDOpen-market purchase | BUY | $30K 16.0K sh | Apr 17, 2026 traded Apr 16, 2026 |